Table 2

Comparison of Patient-Reported Use of Opioids and OTC Analgesics, and Pain Over Time

MeasureWeek 1 (N = 203)Week 2 (N = 202)Week 3 (N = 201)Week 4 (N = 201)Interaction P Valuea
Low Use (n = 90)High Use (n = 113)Low Use (n = 89)High Use (n = 113)Low Use (n = 89)High Use (n = 112)Low Use (n = 89)High Use (n = 112)
Opioids taken,20.1146.02.732.10.9321.60.9315.9.72b
 mean (SD)(23.9)(87.5)(6.6)(53.5)(3.5)(71.2)(3.9)(52.1)
 [median], MMEs[13.1][140.0][0][7.5][0][0][0][0]
Opioids left over,102.874.694.257.089.456.783.354.1.95
 mean (SD)(114.4)(66.6)(108.9)(63.8)(103.9)(75.3)(103.0)(91.0)
 [median], MMEs[80.6][60.0][75.0][37.5][67.5][30.0][45.0][15.0]
OTC analgesics taken, No. (%)
 Acetaminophen21 (23.3)25 (22.1)15 (16.9)26 (23.0)14 (15.7)27 (24.1)9 (10.1)18 (16.1).11
 NSAIDs57 (63.3)72 (63.7)51 (57.3)c88 (77.9)c35 (39.3)c69 (61.6)c26 (29.2)c58 (51.8)c.03
 Both17 (18.9)16 (14.2)12 (13.5)21 (18.6)11 (12.4)19 (17.0)6 (6.7)13 (11.6).08
PROMIS pain, T score (SE)d
 Pain intensity47.2 (5.6)51.7 (5.7)42.9 (6.5)46.9 (6.6)38.6 (6.6)43.8 (7.4)36.5 (6.6)40.5 (7.1).18b
 Pain interference58.5 (6.8)63.7 (6.1)53.0 (7.4)57.0 (7.5)48.7 (7.7)53.3 (8.2)46.0 (7.2)50.1 (8.3).36b
  • MME = milligram morphine equivalent; NSAID = nonsteroidal anti-inflammatory drug; OTC = over the counter; PROMIS = Patient-Reported Outcomes Measurement Information System.

  • Notes: Low use defined as ≤75 MMEs; high use defined as >75 MMEs. Associations between high vs low self-reported opioid use and each predictor were evaluated with separate binomial regressions accounting for repeated measures.

  • a Interaction of predictor by time.

  • b Measures for which a modified Poisson regression approach for clustered data was implemented. Significant predictor-by-week interactions were followed with post hoc tests between groups at each week.

  • c Significant (P <.002) group differences.

  • d A T score of 50 is the average for the US general population, with a standard deviation of 10. Higher scores indicate greater intensity or interference.